Sonoporation-mediated loading of trehalose in cells for cryopreservation. by Shaffer, Charles W., IV et al.
University of Louisville 
ThinkIR: The University of Louisville's Institutional Repository 
Undergraduate Research Events Undergraduate Research 
Fall 9-29-2020 
Sonoporation-mediated loading of trehalose in cells for 
cryopreservation. 
Charles W. Shaffer IV 
University of Louisville 
David F. Grimm 
University of Louisville 
Michael A. Menze 
University of Louisville 
Jonathan A. Kopechek 
University of Louisville 
Follow this and additional works at: https://ir.library.louisville.edu/undergradresearch 
 Part of the Biological Engineering Commons, Cell Biology Commons, and the Molecular Biology 
Commons 
Recommended Citation 
Shaffer, Charles W. IV; Grimm, David F.; Menze, Michael A.; and Kopechek, Jonathan A., "Sonoporation-
mediated loading of trehalose in cells for cryopreservation." (2020). Undergraduate Research Events. 14. 
https://ir.library.louisville.edu/undergradresearch/14 
This Poster is brought to you for free and open access by the Undergraduate Research at ThinkIR: The University of 
Louisville's Institutional Repository. It has been accepted for inclusion in Undergraduate Research Events by an 
authorized administrator of ThinkIR: The University of Louisville's Institutional Repository. For more information, 





Sonoporation in a microfluidics device as a method of
loading trehalose vastly increases the recovery of HepG2
cells with intact plasma membranes after freezing compared
to results utilizing fluid-phase endocytosis. This strategy
eliminates the need for long incubation periods where cells
are exposed to hyperosmotic environments. Sonoporation of
cells in medium that does not contain trehalose improved the
recovery of intact cells after freezing, suggesting that
compounds in the medium itself may confer cryoprotective
effects. Further testing is required to assess the viability and
function of HepG2 cells preserved with this method,
however this approach has the ability to eliminate the need
for cytotoxic cryoprotectant agents, such as DMSO, in
clinical settings.
1. Behm, CA (1997). Int. J. Parasitol, 24(2), 215-226. 2. Centner, C., et al
(2020). Biomicrofluidics, 14(2), 024114. 3. Satpathy, GR, et al (2004).
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Background
Acknowledgments
Human hepatocellular carcinoma (HepG2) cells were used as a model to compare the effectiveness of
trehalose loading using sonoporation or fluid-phase endocytosis before cryopreservation. Cells that
were incubated in culture medium containing 100 mM trehalose were frozen in DMEM + 20% FBS +
100 mM trehalose to -80° C for 24 h at -1° C/min while cells exposed to trehalose during
sonoporation were frozen in either DMEM + 20% FBS + 100 mM or 200 mM trehalose. To assess
membrane integrity after freezing cells were rapidly thawed to 37° C for 2 minutes and intact cells
were identified using a trypan blue exclusion assay. Cells loaded with trehalose via sonoporation
require the presence of lipid microbubbles to cause cavitation. Cells were exposed to the microfluidics
device and sonoporation with concentrations of microbubbles ranging from 0-10% as v/v additions.
Intact cells were enumerated after sonoporation using a trypan blue exclusion assay.
Trehalose, a non-reducing disaccharide, is present in many microorganisms and metazoans. In these
organisms, trehalose acts as a stress protectant and helps preserve lipid membranes of cells during
states of desiccation and freezing1. Trehalose is required on both sides of the cell membrane to
achieve a significant cryoprotective effect. Specific loading methods for trehalose are required since
this sugar is impermeant to mammalian cells3. Trehalose loading in mammalian cells has been
achieved by fluid-phase endocytosis and genetic modification for the expression of trehalose
transporters, however cryoprotective outcomes are unable to compete with established methods of
cryopreservation for mammalian cells4. Sonoporation was achieved using a microfluidics device
modified with an ultrasound emitter in the presence of microbubbles. Ultrasound frequencies emitted
by the transducer result in a process called cavitation, which is the rapid expansion and collapse of
lipid-coated gas-filled bubbles present in the solution. Cavitation of microbubbles creates small jets of
liquid that can create membrane pores that are 150-300 nm in size and quickly reseal through budding
and exocytosis allowing for uptake of impermeant compounds, such as trehalose5.
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Fig. 1. A) Picture of the ultrasonic
flow system. Ultrasound transducers
are combined with PDMS-based
fluidic devices inside a 3D-printed
portable case to enable sequential and
consistent loading of compounds
across cellular membranes. B)
Cartoon of microbubble (MB) rupture
leading to active transport of
compounds across cell membranes
(not to scale)2.
Discussion
Fluid-phase endocytosis is inefficient as a method of trehalose
loading for cryopreservation. Exposing HepG2 cells to 100 mM
trehalose during sonoporation improved the recovery of intact
cells after freezing when compared to cells incubated in medium
containing 100 mM trehalose. Using a freezing medium
containing 200 mM trehalose increased the recovery of intact cells
after freezing compared to medium supplemented with 100 mM
trehalose. Further, increasing the trehalose concentration to 400
and 500 mM during sonoporation improved intact cell recovery to
80 and 85% respectively. A 2.5% v/v dose of microbubbles was
determined to be optimal for the loading of trehalose without
excessive toxicity to HepG2 cells. These results indicate that
ultrasound-mediated sonoporation is an effective trehalose loading
strategy for cryopreservation of HepG2 cells.
Fig. 2. Assessment of microbubble and process
toxicity for HepG2 cells. The percentage of cells
with intact plasma membranes was calculated after
flowing through the device without exposure to
microbubbles or ultrasound (Flow), without
microbubbles in presence of ultrasound (Flow + US),
or with ultrasound and a range of microbubble
concentrations. Microbubble dosages were calculated
as v/v additions (n = 3, ± SE).
Fig. 3. Percentage of intact cells recovered after
freezing of suspended cells exposed to trehalose via
fluid-phase endocytosis or sonoporation. HepG2
cells were either incubated with trehalose for 24 h
(gray bars) or were exposed to trehalose during
sonoporation (red bars) and all cells were frozen to
-80 °C in culture medium supplemented with 100
mM trehalose and 20% FBS. An increase in recovery
of intact HepG2 cells after freezing is observed for
sonoporated cells (n = 3, ± SE). *Indicates
statistically significant difference compared to
fluid-phase endocytosis. Significance level was set at
p ≤ 0.05.
Fig. 4. Percentage of intact cells recovered after
freezing of suspended cells exposed to 100 mM
trehalose during sonoporation. HepG2 cells were
frozen in culture medium supplemented with 100
mM trehalose (red bar) or 200 mM trehalose (green
bar) and 20% FBS. Freezing of cells in medium
containing 200 mM trehalose yielded the highest
recovery of intact cells (n = 3, ± SE). *Indicates
statistically significant difference compared to
freezing medium containing 100 mM trehalose.
Significance level was set at p ≤ 0.05.
Fig. 5. Percentage of intact HepG2 cells recovered
after freezing of cells loaded with trehalose via
sonoporation. 400 and 500 mM trehalose yielded the
highest intact cell recovery (n = 3, ± SE). *Indicates
statistically significant differences between groups.
Significance level was set at p ≤ 0.05.
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